Gutology Limited

Gutology Limited, based in the UK, specializes in microbiome health through innovative products that enhance oral and gut health, providing natural solutions for health-conscious consumers. Founded in 2020 in the UK by Ollie Gallant, Gutology Limited focuses on health products that support microbiome balance. Gutology focuses on rebalancing the human microbiome through innovative health products designed for daily use. Their core offerings include a natural toothpaste formulated to clean teeth and protect the oral microbiome, addressing common dental issues while utilizing active ingredients such as hydroxyapatite and oral probiotics.

This product stands out in the market by avoiding harmful chemicals and promoting overall oral health, thus appealing to health-conscious consumers. In addition to oral care, Gutology provides microbiome testing services, where customers can assess their gut health through comprehensive tests that analyze key microbiome markers and identify beneficial and harmful bacteria, as well as potential digestive issues. The company’s products are primarily marketed to health-conscious individuals in the United States and the United Kingdom, seeking alternatives to conventional oral care and gut health solutions. Gutology generates revenue through direct-to-consumer sales of its health products, including its flagship natural toothpaste and microbiome testing kits.

The company operates on a transactional model that allows customers to purchase individual products or subscribe to regular shipments for essentials, thereby enhancing customer retention and loyalty. The pricing structure includes individual products available at set prices, such as the toothpaste and various testing add-ons, which provide insights into specific health concerns. By offering tailored products and services to its consumers, Gutology effectively serves its client base and fosters a robust revenue stream from both standalone purchases and potential subscription models. The company's emphasis on high-quality, scientifically-backed products positions it favorably within the health and wellness market.

In January 2026, Gutology Limited raised EUR 2 million in venture funding from Mercia Asset Management and Active Partners. The company will use the funding to support the further development of its product and expansion plans initiatives. Future growth strategies include the launch of new products targeted to enhance microbiome health and plans to expand into new markets, specifically targeting regions in Europe and North America by the end of 2027.